Lead Sponsor

CanSino Biologics Inc.

Collaborators

Age

0 - No limit years

Sex

ALL

Healthy Volunteers

Yes

•Healthy subjects of 2 months (minimum 6 weeks), 3 months , 7 months and above;
•Willing to provide proof of identity;
•Without vaccination history of pneumococcal vaccine;
•None-pregnancy or do not plan to pregnancy recently;;
•Volunteers of 18 years old and above who have the ability to understand clinical studie progress and sign informed consent;
•Volunteers of 8-17 years old and their guardians who willing sign informed consent;
•Able to understand and sign the informed consent by their guardians or trustees for the volunteers of 8 years old and below;
•Able and willing comply with the requirements of the protocol

•Volunteers whose axillary body temperature was \>37.0# before vaccination
•Volunteers who suffered from Congenital malformation or developmental disorder, genetic defect, severe malnutrition, etc;
•Volunteers who has a history of epilepsy, convulsions or psychosis;
•Allergic person;
•Any prior administration of blood products in last 3 month;
•Any prior administration of other research medicines in last 1 month;
•Plans to participate in or is participating in any other drug clinical study;
•Any prior administration of attenuated live vaccine in last 14 days;
•Any prior administration of subunit or inactivated vaccines in last 7 days;
•Had fever before vaccination, Volunteers with temperature \>37.0°C on axillary setting;
•According to the investigator's judgement, the subjects have any other factors that make them unfit to enroll the clinical trial

Related studies

NCT06704048 · Infective Endocarditis, Bacterial Infections, and more

NCT04263792 · Bacterial Infections

NCT07343167 · Streptococcal Infections

NCT06135350 · Gram Negative Pneumonia, Gram-Negative Bacterial Infections, and more

NCT06998251 · Pneumococcal Infections, Respiratory Syncytial Virus (RSV) Infection, and more

Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)